Cargando…

Competing risk of death and end-stage renal disease in incident chronic kidney disease (stages 3 to 5): the EPIRAN community-based study

BACKGROUND: Although chronic kidney disease (CKD) affects a growing number of people, epidemiologic data on incident CKD in the general population are scarce. Screening strategies to increase early CKD detection have been developed. METHODS: From a community-based sample of 4,409 individuals residin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ayav, Carole, Beuscart, Jean-Baptiste, Briançon, Serge, Duhamel, Alain, Frimat, Luc, Kessler, Michèle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5111196/ https://www.ncbi.nlm.nih.gov/pubmed/27846810 http://dx.doi.org/10.1186/s12882-016-0379-3

Ejemplares similares

Targets for parathyroid hormone in secondary hyperparathyroidism: is a “one-size-fits-all” approach appropriate? A prospective incident cohort study
por: Laurain, Emmanuelle, et al.
Publicado: (2014)

Overestimation of the probability of death on peritoneal dialysis by the Kaplan-Meier method: advantages of a competing risks approach
por: Beuscart, Jean-Baptiste, et al.
Publicado: (2012)

Competing-risk analysis of death and dialysis initiation among elderly (≥80 years) newly referred to nephrologists: a French prospective study
por: Faller, Bernadette, et al.
Publicado: (2013)

Predialysis therapeutic care and health-related quality of life at dialysis onset (The pharmacoepidemiologic AVENIR study)
por: Boini, Stephanie, et al.
Publicado: (2011)

Lack of Monitoring Is Associated with Risk of Acute Kidney Events among Patients with Inflammatory Bowel Disease
por: Achit, Hamza, et al.
Publicado: (2022)

Trajectories of CKD-MBD biochemical parameters over a 2-year period following diagnosis of secondary hyperparathyroidism: a pharmacoepidemiological study
por: Filipozzi, Pierre, et al.
Publicado: (2017)

Competing Risk Analyses of Patients with End-Stage Renal Disease
por: Tabrizi, Reza, et al.
Publicado: (2015)

Are segments of the developing world competing in end-stage renal disease (ESRD)?
por: Mungrue, Kameel
Publicado: (2008)

Eosinophilia and risk of incident end stage kidney disease
por: Tariq, Anam, et al.
Publicado: (2020)

Registration on the Renal Transplantation Waiting List and Mortality on Dialysis: an Analysis of the French REIN Registry Using a Multi-state Model
por: Beuscart, Jean-Baptiste, et al.
Publicado: (2015)

Chronic Kidney Disease and the Risk of End-Stage Renal Disease versus Death
por: Dalrymple, Lorien S., et al.
Publicado: (2010)

Incidence of sudden cardiac death in adults with end-stage renal disease: a systematic review and meta-analysis
por: Ramesh, Sharanya, et al.
Publicado: (2016)

Access to Care and the Incidence of End-Stage Renal Disease Due to Diabetes
por: Ward, Michael M.
Publicado: (2009)

Is incidence of prostate cancer higher in patients with end stage renal disease?
por: Khochikar, Makarand V.
Publicado: (2007)

Methods of competing risks analysis of end-stage renal disease and mortality among people with diabetes
por: Lim, Hyun J, et al.
Publicado: (2010)

Competing-Risk Analysis of Death and End Stage Kidney Disease by Hyperkalaemia Status in Non-Dialysis Chronic Kidney Disease Patients Receiving Stable Nephrology Care
por: Provenzano, Michele, et al.
Publicado: (2018)

Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients
por: Couchoud, Cécile, et al.
Publicado: (2020)

Death Does Matter—Cancer Risk in Patients With End-Stage Renal Disease: A Nationwide Population-Based Study With Competing Risk Analyses
por: Weng, Shih-Feng, et al.
Publicado: (2016)

The Medicare experience with end-stage renal disease: Trends in incidence, prevalence, and survival
por: Eggers, Paul W., et al.
Publicado: (1984)

The Gap between Estimated Incidence of End-Stage Renal Disease and Use of Therapy
por: Anand, Shuchi, et al.
Publicado: (2013)

Trends in the Incidence, Prevalence, and Mortality of End-Stage Kidney Disease in South Korea
por: Lee, Min-Jeong, et al.
Publicado: (2020)

Albumin for End-Stage Liver Disease
por: Lee, June Sung
Publicado: (2012)

End Stage Renal Disease and Medicare
por: Greer, Joel W.
Publicado: (2003)

End of Life Care in End-Stage Kidney Disease
por: Prabhu, Ravindra Attur, et al.
Publicado: (2021)

Refitting the Model for End‐Stage Liver Disease for the Eurotransplant Region
por: Goudsmit, Ben F. J., et al.
Publicado: (2021)

Intégration dans le parcours patient des transplantés rénaux d’un suivi par télésurveillance–expérimentation ETAPES
por: Ayav, C., et al.
Publicado: (2020)

Incidence and Predictors of End Stage Renal Disease among Low-Income Blacks and Whites
por: Lipworth, Loren, et al.
Publicado: (2012)

Reduced incidence of end stage renal disease among the elderly in Denmark: an observational study
por: Heaf, James G, et al.
Publicado: (2012)

Urine 6-Bromotryptophan: Associations with Genetic Variants and Incident End-Stage Kidney Disease
por: Sekula, Peggy, et al.
Publicado: (2020)

Incidence, risk factors and distribution of syphilis in the end-stage renal disease population in the USA
por: Weathers, Erena N, et al.
Publicado: (2019)

The prevalence and incidence of vertebral fractures in end-stage renal disease and the role of parathyroid hormone
por: Jansz, T. T., et al.
Publicado: (2019)

Nationwide Glaucoma incidence in end stage renal disease patients and kidney transplant recipients
por: Moon, Jong Joo, et al.
Publicado: (2021)

Chronic kidney disease in primary care: risk of cardiovascular events, end stage kidney disease and death
por: Borg, Rikke, et al.
Publicado: (2023)

Model for End-Stage Liver Disease Correlates with Disease Relapse and Death of Patients with Merkel Cell Carcinoma
por: Gambichler, Thilo, et al.
Publicado: (2023)

Cost-effectiveness of home telemonitoring in chronic kidney disease patients at different stages by a pragmatic randomized controlled trial (eNephro): rationale and study design
por: Thilly, Nathalie, et al.
Publicado: (2017)

Accounting for the Competing Risk of Death to Predict Kidney Failure in Adults With Stage 4 Chronic Kidney Disease
por: Al-Wahsh, Huda, et al.
Publicado: (2021)

No increase in small-solute transport in peritoneal dialysis patients treated without hypertonic glucose for fifty-four months
por: Pagniez, Dominique, et al.
Publicado: (2017)

Evaluation of laboratory values affecting mortality of end-stage renal disease patients: a competing risks approach
por: Malek, Rayka, et al.
Publicado: (2023)

Fabry Disease Presenting as End-Stage Kidney Disease
por: Pahl, Madeleine V., et al.
Publicado: (2023)

Increased risk of death in African American patients with end-stage renal disease secondary to lupus
por: Sule, Sangeeta, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3jfc78oidp97qg5ft6ehk647n9